GLADYS TANUI: Open Payments
NPI 1215439401 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120 in 6 payments from 5 companies in 2025. Trend: 2023 $123 · 2024 $88 · 2025 $120
Food & beverage: $120
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: ENTYVIO, ZENPEP, VEGZELMA, SUFLAVE, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
